Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 7 chart positions in 7 markets.
By chart position
- 🇨🇦CA · Medicine#1285K to 30K
- 🇮🇳IN · Medicine#1101K to 10K
- 🇧🇷BR · Medicine#1211K to 10K
- 🇯🇵JP · Medicine#1541K to 10K
- 🇲🇽MX · Medicine#1621K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
6.5K to 45K🎙 Weekly cadence·193 episodes·Last published 4d ago - Monthly Reach
Unique listeners across all episodes (30 days)
13K to 90K🇨🇦33%🇮🇳11%🇧🇷11%+4 more - Active Followers
Loyal subscribers who consistently listen
5.2K to 36K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis
May 28, 2026
33m 24s
The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis
May 14, 2026
34m 35s
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)
Apr 30, 2026
35m 19s
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease
Apr 23, 2026
46m 17s
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Mar 26, 2026
16m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/28/26 |  Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis | Dr. Mohleen Kang speaks with Dr. Chris Ryerson, Dr. Johannson, and Dr. Fernández Pérez about their papers, "Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography" and "Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia." | 33m 24s | ||||||
| 5/14/26 | The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis | Dr. John Fleetham speaks with Dr. Leonardo Martinez about his article, "The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis." | 34m 35s | ||||||
| 4/30/26 |  Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3) | Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, "Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)." | 35m 19s | ||||||
| 4/23/26 |  Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease | Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease." | 46m 17s | ||||||
| 3/26/26 |  Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline." | 16m 39s | ||||||
| 2/26/26 | “Social Apnea”: Obstructive Sleep Apnea Is Exacerbated on Weekends | Dr. John Fleetham chats with Danny Eckert about his article, "Obstructive Sleep Apnea is Exacerbated on Weekends." | 22m 31s | ||||||
| 2/19/26 | A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis and One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease | Dr. Mohleen Kang chats with Dr. Stephen Humphries, Dr. Matthew Koslow, Dr. Justin Oldham, Dr. Jennifer Wang, Alexander Bankier, and Dr. David Baraghoshi about their articles, "A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis" and "One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease." | 48m 04s | ||||||
| 2/5/26 | Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis | Dr. Michael Lanspa chats with Dr. Natasha Spottiswoode and Chaz Langelier about their article, "Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis." | 30m 04s | ||||||
| 1/29/26 |  Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids | Dr. John Fleetham chats with Dr. Barbro N Melgert and Dr. Chris Carlsten about their articles, "Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation" and "Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids." | 25m 59s | ||||||
| 11/27/25 |  Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial | Dr Michael Lanspa chats with Dr. Imeen van der Wal and Dr. Chloe Grim on their article, "Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial." | 17m 14s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/13/25 | Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline | Dr. John Fleetham chats with Dr. Barbara Jones about her ATS guideline, "Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline." | 30m 34s | ||||||
| 11/6/25 |  Is CT Screening For Lung Cancer Generalizable to Older Patients? | In this podcast, we review a comparison of outcomes in patients 65-74 years old from SEER-Medicare and NLST datasets in stage I lung cancer with study first author, Dr. Nichole Tanner as well as Dr. Neal Navani. | 38m 04s | ||||||
| 9/4/25 | Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis | Dr. Mohleen Kang chats with Dr. Justin Oldham, Dr. Chad Newton and Dr. Jesse Roman about their papers, "Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis" and "Progress in Progressive Pulmonary Fibrosis." | 21m 24s | ||||||
| 8/28/25 | A New Global Definition of Acute Respiratory Distress Syndrome | Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, "A New Global Definition of Acute Respiratory Distress Syndrome." | 33m 36s | ||||||
| 8/21/25 | Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease | Dr. John Fleetham chats with Dr. Chris Ryerson and Dr. Yet Khor about their article, "Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease." | 21m 32s | ||||||
| 7/17/25 | Approach to the Evaluation and Management of Interstitial Lung Abnormalities | Dr. Mohleen Kang chats with Dr. Anna Podolanczuk and Dr. Gary Hunninghake about their article, "Approach to the Evaluation and Management of Interstitial Lung Abnormalities." | 30m 28s | ||||||
| 7/10/25 | Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough? | Dr. John Fleetham chats with Dr. Jaclyn Smith and Dr. Imran Satia about their articles, "Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?" | 28m 51s | ||||||
| 6/19/25 |  Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III) | This episode originally aired on March 23rd, 2023. Dr. Michael Lanspa chats with Dr. Yahya Shehabi about his article, "Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III)." | 33m 55s | ||||||
| 5/29/25 | Early vs. Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation | Dr. Michael Lanspa chats with Dr. Carmen Reep and Dr. Leo Heunks about their article, "Early vs. Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation." | 24m 51s | ||||||
Showing 19 of 197
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
7 placements across 7 markets.
Chart Positions
7 placements across 7 markets.